All In MedTech

FDA Clearance Tracker · P860026-S008

DIAPHRAGMATIC PACEMAKER PHRENIC NERVE STIMULATOR

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 21, 2026Latest source record: Mar 3, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P860026-S008
Device name
DIAPHRAGMATIC PACEMAKER PHRENIC NERVE STIMULATOR
Applicant location
Commack, NY
Received
Sep 11, 2002
Decided
Mar 3, 2003
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P860026

Device type

Device class
Class III
Regulation
21 CFR 882.5830

Every decision under product code GZE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR SELECTING A FINAL VALUE OF C22 AND C50 CAPACITORS DURING PRODUCTION TESTING BASED ON PARAMETERS MEASURED WITH CALIBRATED TEST EQUIPMENT TO RESULT IN PEAK OPERATING PERFORMANCE OF THE TRANSMITTER.

Source documents

Other decisions for Avery Biomedical Devices, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.